Document Detail


Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy.
MedLine Citation:
PMID:  15071769     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 16-year-old patient with steroid-dependent nephrotic syndrome with more than 35 relapses developed severe relapsing idiopathic thrombocytopenic purpura (ITP). At the age of 2 years, nephrotic syndrome was diagnosed and successfully treated with a standard prednisone regimen. Frequent relapses occurred. Treatment with oral cyclophosphamide followed by cyclosporine was successful, but several attempts to withdraw steroids failed and the patient suffered from multiple relapses. At the age of 12 years, renal biopsy revealed focal segmental glomerulosclerosis and cyclosporine toxicity. A second course of oral cyclophosphamide was unsuccessful and tacrolimus resulted in the development of diabetes mellitus, which was reversed after discontinuation of the drug. At the age of 15 years the patient, still being steroid dependent, developed ITP. Neither steroids nor intravenous immunoglobulins induced permanent remission. Only weekly immunoglobulin infusions could temporarily restore the platelet count. To treat ITP in this desperate situation we decided to deplete B-cells with the monoclonal anti-CD20 antibody rituximab. Intravenous infusions of rituximab (375 mg/m(2)) were given once weekly for 4 consecutive weeks without adverse events. Four weeks after the first rituximab dosage, the thrombocyte count increased to normal values. There has been no subsequent relapse of either thrombocytopenia or nephrotic syndrome (on cyclosporine, without steroids) to date. We conclude that B-cell depletion with rituximab might have altered the course of steroid-dependent nephrotic syndrome in our patient.
Authors:
Kerstin Benz; Jörg Dötsch; Wolfgang Rascher; Daniel Stachel
Related Documents :
10872189 - Steroid-sensitive nephrotic syndrome associated with kimura disease.
7055089 - Giant lymph node hyperplasia involving the thymus with associated nephrotic syndrome an...
16939069 - Nephrotic syndrome with focal segmental glomerulosclerosis after an insect bite.
421189 - Retroperitoneal paraganglioma and systemic amyloidosis: a case report.
16088079 - Jejunal dopamine and na,k+-atpase activity in nephrotic syndrome.
12381959 - Guillain-barré syndrome associated with minimal change glomerulopathy and tubular dysf...
17696269 - Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.
3563899 - Reiter's syndrome and recurrent peritonitis after appendectomy.
2486649 - Guillain-barre syndrome after obstetrical epidural analgesia.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2004-04-08
Journal Detail:
Title:  Pediatric nephrology (Berlin, Germany)     Volume:  19     ISSN:  0931-041X     ISO Abbreviation:  Pediatr. Nephrol.     Publication Date:  2004 Jul 
Date Detail:
Created Date:  2004-06-02     Completed Date:  2005-03-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8708728     Medline TA:  Pediatr Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  794-7     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, University of Erlangen-Nürnberg, Loschgestrasse 15, 91054 Erlangen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Antibodies, Monoclonal / therapeutic use*
Child, Preschool
Follow-Up Studies
Glucocorticoids / therapeutic use
Humans
Male
Nephrotic Syndrome / drug therapy*
Prednisone / therapeutic use
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Glucocorticoids; 0/rituximab; 53-03-2/Prednisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands...
Next Document:  The prognostic value of glomerular immaturity in the nephrotic syndrome in children.